(Q43948719)

28 November 2017

title

Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans (English)

1 reference

28 November 2017

0 references

1

1 reference

28 November 2017

5

Ele Ferrannini

1 reference

28 November 2017

author name string

Panithaya Chareonthaitawee

2

1 reference

28 November 2017

Marco Di Terlizzi

3

1 reference

28 November 2017

D John Betteridge

4

1 reference

28 November 2017

Paolo G Camici

6

1 reference

28 November 2017

publication date

1 May 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

28 November 2017

published in

1 reference

28 November 2017

volume

282

1 reference

28 November 2017

issue

5

1 reference

28 November 2017

page(s)

E1163-71

1 reference

Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Evidence that nitric oxide increases glucose transport in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

An examination of the measurement of flow heterogeneity in striated muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Metabolic and hemodynamic effects of insulin on human hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Metabolic vasodilatation with glucose-insulin-potassium does not change the heterogeneous distribution of coronary blood flow in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Regional differences in myocardial performance in the left ventricle of the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin resistance and vasodilation in essential hypertension. Studies with adenosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Myocardial utilization of carbohydrate and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin resistance in patients with cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Nitric oxide release accounts for insulin's vascular effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Kinetics of glucose disposal in whole body and across the forearm in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

Dynamic, Gated and High Resolution Imaging with the ECAT III

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00386.2001

10.1152/AJPENDO.00386.2001

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference